legislation: 115-s-3770
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115-s-3770 | 115 | s | 3770 | Medicaid Drug Decisions Transparency Act | Health | 2018-12-18 | 2018-12-18 | Read twice and referred to the Committee on Finance. | Senate | Sen. Booker, Cory A. [D-NJ] | NJ | D | B001288 | 0 | Medicaid Drug Decisions Transparency Act This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations. | 2023-01-11T13:40:39Z |